Subsequent use of CRISPR genome editing, to disrupt the mouse GAL5.1 enhancer (mGAL5.1KO), demonstrated a role for mGAL5.1 in the tissue specific expression of the Gal gene in hypothalamus and amygdala as well as the modulation of alcohol intake and male anxiety-like behaviour [24]. The gene discussed is GAL; the disease is Anxiety.